Belmonti, Simone
 Distribuzione geografica
Continente #
NA - Nord America 260
EU - Europa 162
AS - Asia 141
SA - Sud America 24
AF - Africa 10
Totale 597
Nazione #
US - Stati Uniti d'America 254
SG - Singapore 69
SE - Svezia 43
CN - Cina 38
IT - Italia 38
FR - Francia 20
BR - Brasile 18
DE - Germania 18
IE - Irlanda 10
IN - India 9
CM - Camerun 8
VN - Vietnam 6
AR - Argentina 5
BD - Bangladesh 5
FI - Finlandia 5
GB - Regno Unito 5
ID - Indonesia 5
PL - Polonia 5
UA - Ucraina 5
BE - Belgio 3
MX - Messico 3
CA - Canada 2
HK - Hong Kong 2
IL - Israele 2
JP - Giappone 2
LT - Lituania 2
NL - Olanda 2
RU - Federazione Russa 2
BY - Bielorussia 1
CH - Svizzera 1
EC - Ecuador 1
ES - Italia 1
IR - Iran 1
KE - Kenya 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
TT - Trinidad e Tobago 1
ZA - Sudafrica 1
Totale 597
Città #
Chandler 48
Singapore 27
Ann Arbor 19
Ashburn 18
New York 14
Cattolica 11
Dublin 10
Jacksonville 10
Beijing 8
Redwood City 8
San Mateo 8
Los Angeles 7
Nanjing 6
Woodbridge 6
Frankfurt am Main 5
Houston 5
Jakarta 5
The Dalles 5
Ho Chi Minh City 4
Lancaster 4
Milan 4
Rome 4
Boston 3
Brussels 3
Dallas 3
Kraków 3
Lauterbourg 3
Princeton 3
Queens 3
São Paulo 3
Wilmington 3
Amsterdam 2
Auburn Hills 2
Boardman 2
Buenos Aires 2
Cambridge 2
Campinas 2
Ciampino 2
Dearborn 2
Fairfield 2
Guangzhou 2
Hong Kong 2
Lawrence 2
Ottawa 2
Paris 2
Querétaro 2
Shenyang 2
Tianjin 2
Tokyo 2
Warsaw 2
Andover 1
Berlin 1
Biên Hòa 1
Brooklyn 1
Buffalo 1
Carlos Casares 1
Chaguanas 1
Chicago 1
Chongqing 1
Colombo 1
Curitiba 1
Denver 1
Dhaka 1
Durban 1
Düsseldorf 1
Ensenada 1
Fairfax 1
Guayaquil 1
Haifa 1
Harbin 1
Hebei 1
Hefei 1
Hialeah 1
Hinesville 1
Igarassu 1
Ivano-Frankivsk 1
Jiaxing 1
Jinan 1
Juiz de Fora 1
Juneau 1
La Plata 1
Miami 1
Minaçu 1
Mountain View 1
Nairobi 1
Nanchang 1
Nizhniy Novgorod 1
Norwalk 1
Nova Iguaçu 1
Oklahoma City 1
Petrolina 1
Planalto 1
Pokrovske 1
Pomezia 1
Pune 1
Ribeirão Preto 1
Riga 1
Santo André 1
Seattle 1
Shenzhen 1
Totale 351
Nome #
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 142
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study 136
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 123
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 117
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy 89
Totale 607
Categoria #
all - tutte 2.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.572


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 6 5 2 2 0 2 1
2021/202256 2 1 1 7 3 2 2 9 4 4 9 12
2022/2023116 21 18 7 18 7 11 1 13 17 1 2 0
2023/202462 3 18 6 7 1 14 2 0 0 0 11 0
2024/202592 0 1 6 6 11 4 2 7 16 6 21 12
2025/2026116 35 3 6 29 40 3 0 0 0 0 0 0
Totale 607